Retour aux projets

16015.2 PFLS-LS

16015.2 PFLS-LS

Résumé

Rendering Cats Hypoallergenic by Vaccination

Textes supplémentaires

Abstract

Allergy to cats is an important cause of discomfort and asthma and consequent health care expenditure and loss of productivity. It is proposed to develop, produce and market a vaccine for cats against their own allergenic proteins. After vaccination less allergen is present on fur, and humans in contact with such cats are less exposed, thus reducing symptoms in allergic persons and reducing the risk of becoming allergic in non-allergic persons.

Participants

Gabriela Senti

Wirtschaftspartner

gabriela.senti@usz.ch

Hypo Pet (UZH Spin off -in formatio Gabriela Senti 8091 Zürich ZH CH

Thomas Kündig

Kontaktperson

thomas.kuendig@usz.ch

USZ Universitätsspital Zürich Dermatologie Thomas Kündig Gloriastrasse 31 8091 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2014-06-30
Date de fin
2018-06-30
Coûts totaux approuvés
CHF 799161.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%